Celgene to discontinue treatment with REVLIMID in phase III ORIGIN trial

Posted in: Drug Trial News | Medical Condition News

Tags: Anemia, Angioedema, Anorexia, Anti-Inflammatory, Arthralgia, Back Pain, Basal Cell Carcinoma, Birth Control, birth defects, Blood Donation, Cancer, Carcinoma, Cell, Chronic Lymphocytic Leukemia, Chronic…
Source: Celgene to discontinue treatment with REVLIMID in phase III ORIGIN trial

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: